ONTOZRY® Update - Epilepsy Ireland make submission to NCPE supporting reimbursement of the drug
Epilepsy Ireland have made a submission to the National Centre for Pharmacoeconomics (NCPE) supporting the reimbursement of ONTOZRY® (Cenobamate), in Ireland.